Home India Ministry of Chemicals and Fertilizers Addendum to S.O. 3934(E) dated 23.09.2021...
Date: 2021-10-12 Category: Extra Ordinary State: Union Government Country: India

Addendum to S.O. 3934(E) dated 23.09.2021

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

This document is an addendum to a notification (S.O. 3934(E)) issued by the National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, on September 23, 2021, regarding the fixation of retail prices of certain pharmaceutical formulations. The addendum, dated October 12, 2021, specifically concerns an amendment to Entry No. 2 in the table provided in the original notification. The amendment replaces the manufacturer of Methotrexate Topical Gel, with strength 1 GM. The original manufacturer, Ms Ajanta Healthcare Pvt. Ltd, is replaced with Ms Alaina Healthcare Pvt. Ltd. The marketing company, Ms IPCA Laboratories Ltd., and the retail price remain unchanged. All other notes and content from the original order (S.O. 3934(E)) remain in effect. The addendum is issued under notification number S.O. 4241(E) and reference number PN224922021/F. No. 8922021/D.P.NPPA/Div.II. The issuing authority is Prasenjit Das, Deputy Director, NPPA.

Key Entities Referenced

National Pharmaceutical Pricing Authority: An organization under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, responsible for price control of pharmaceuticals in India. S.O. 4241E: A notification number issued by the National Pharmaceutical Pricing Authority. S.O. 3934E: A previous notification number issued by the National Pharmaceutical Pricing Authority on 23rd September, 2021, regarding the fixation of retail price. Ministry of Chemicals and Fertilizers: A ministry of the Government of India. Department of Pharmaceuticals: A department under the Ministry of Chemicals and Fertilizers. Methotrexate IP: A scheduled formulation mentioned in the notification, specifically Methotrexate Topical Gel. Ajanta Healthcare Pvt. Ltd.: A manufacturer of Methotrexate Topical Gel. IPCA Laboratories Ltd.: Marketing Company of Methotrexate Topical Gel.
Official Source Record View Original Source →
See Full Document Text
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99 xxxGIDHxxx सी.जी.-डी.एxलxx.-GअID.E-1x2xx1 02021-230372 CG-DL-E-12102021-230372 असाधारण EXTRAORDINARY भाग II—खण्ड 3—उप-खण्ड (ii) PART II—Section 3—Sub-section (ii) प्राजधकार स ेप्रकाजित PUBLISHED BY AUTHORITY स.ं 3894] नई दद्ली, मगं लवार, अक्त बू र 12, 2021/आज‍व न 20, 1943 No. 3894] NEW DELHI, TUESDAY, OCTOBER 12, 2021/ASVINA 20, 1943 ubZ fnYyh] 12 vDrwcj] 2021 — , blds LFkku ij (1) (2) (3) (4) (5) (6) 2 संयोिन: मैससस अिंता 13.21 ह्े थकेयर प्रा. मेथोरेक्सेट मेथोरेक्सेट आईपी 1.0% 1 िी एम जलजमटेड / मैससस सामजयक िेल डब्‍ ् य/ूडब्‍ ् य ू आईपीसीए लेबोरेटरीि जलजमटेड 5849 GI/2021 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] i<k+ tk, (1) (2) (3) (4) (5) (6) 2 संयोिन: मैससस अलाईना 13.21 ह्े थकेयर प्रा. मेथोरेक्सेट आईपी 1.0% मेथोरेक्सेट 1 ग्राम. जलजमटेड / मैससस सामजयक िेल डब्‍ ् य/ूडब्‍ ् य ू आईपीसीए लेबोरेटरीि जलजमटेड fnukad 23 flrEcj] 2021 ds ewy vkn's k dk-vk- 3934¼v½] es a mYysf[kr lHkh uksV~l vkSj vU; lekxzh leku jgsxhA [dk-a la-@224@92@2021@,Q@Qk- la- 8¼92½@2021@Mhih@,uihih,&fMoh-II] izlsuthr nkl] mi fun's kd MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ADDENDUM New Delhi, the 12th October, 2021 S.O. 4241(E).—In the National Pharmaceutical Pricing Authority's notification S.O. 3934(E), dated 23rd September, 2021 relating to fixation of retail price, published in the Gazette of India, Extraordinary, the Entry at Sl. No. 2 of the Table, both in Hindi & English version, be read as follows : Instead of Sl. Name of the Scheduled Strength Unit Manufacturer & Retail Price No. Formulation / Brand Marketing Company (Rs.) Name (1) (2) (3) (4) (5) (6) 2 Composition: 13.21 M/s Ajanta Healthcare Methotrexate IP Methotrexate Topical Gel 1 GM Pvt. Ltd. / M/s IPCA 1.0% w/w Laboratories Ltd. Read as[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 3 Sl. Name of the Scheduled Strength Unit Manufacturer & Retail Price No. Formulation / Brand Marketing (Rs.) Name Company (1) (2) (3) (4) (5) (6) 2 Composition: M/s Alaina 13.21 Methotrexate IP Healthcare Pvt. Methotrexate Topical Gel 1 GM 1.0% w/w Ltd. / M/s IPCA Laboratories Ltd. All the notes and other contents mentioned in the original order S.O. 3934(E), dated 23rd September, 2021 shall remain same. [PN/224/92/2021/F/F. No. 8(92)/2021/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research